Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultevursen in Retinitis Pigmentosa (CAPELLA)
NCT07796646Phase 2Not yet recruiting
- Sponsor
- Laboratoires Théa
- Start
- Oct 2026
- Primary completion
- Feb 2030
01
Overview
A Phase 2 trial of ultevursen in retinitis pigmentosa (RP), sponsored by Laboratoires Théa. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ultevursen
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT07796646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796646.